A systematic review of randomised control trials on the effects of yoga on stress measures and mood

Journal of Psychiatric Research

Volumn 68, Issue , 2015, Pages 270-282

  Pascoe, Michaela C ^a   Bauer, Isabelle E ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Anxiety; Brain imaging; Depression; Exercise; Inflammation; Mood; Stress; Yoga

Indexed keywords

HYDROCORTISONE;

ADRENERGIC SYSTEM; AROUSAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; HEART RATE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MOOD; PHYSIOLOGICAL STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVA ANALYSIS; STRESS; SYMPTOMATOLOGY; SYSTEMATIC REVIEW; WAKEFULNESS; YOGA; AUTONOMIC NERVOUS SYSTEM DISEASES; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

AUTONOMIC NERVOUS SYSTEM DISEASES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; PITUITARY-ADRENAL SYSTEM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STRESS, PSYCHOLOGICAL; YOGA;

EID: 84937877810     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2015.07.013     Document Type: Article

References (147)

1. Abercrombie H.C., et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 1998, 9(14):3301-3307.
2. Ashman S.B., et al. Stress hormone levels of children of depressed mothers. Dev. Psychopathol. 2002, 14(2):333-349.
3. Australian Sports Commission, t.S.R.G.S. Participation in Exercise, Recreation and Sport in Australia 2010, The Australian Government.
4. Autry A.E., Monteggia L.M. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 2012, 64(2):238-258.
5. Avenevoli S., et al. Comorbidity of depression in children and adolescents: models and evidence from a prospective high-risk family study. Biol. Psychiatry 2001, 49(12):1071-1081.
6. Badrick E., Kirschbaum C., Kumari M. The relationship between smoking status and cortisol secretion. J.Clin. Endocrinol. Metabolism 2007, 92(3):819-824.
7. Balasubramaniam M., Telles S., Doraiswamy P.M. Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders. Front. Psychiatry 2012, 3:117.
8. Baldwin D.S., et al. Can we distinguish anxiety from depression?. Psychopharmacol. Bull. 2002, 36(Suppl.2):158-165.
9. Banasik J., et al. Effect of Iyengar yoga practice on fatigue and diurnal salivary cortisol concentration in breast cancer survivors. J.Am. Acad. Nurse Pract. 2011, 23(3):135-142.
10. Banerjee B., et al. Effects of an integrated yoga program in modulating psychological stress and radiation-induced genotoxic stress in breast cancer patients undergoing radiotherapy. Integr. Cancer Ther. 2007, 6(3):242-250.
11. Berk M., et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci. Biobehav Rev. 2011, 35(3):804-817.
12. Bouayed J., Rammal H., Soulimani R. Oxidative stress and anxiety relationship and cellular pathways. Oxidative Med. Cell. Longev. 2009, 2(2):63-67.
13. Bowden D., et al. Acomparative randomised controlled trial of the effects of brain wave vibration training, iyengar yoga, and mindfulness on mood, well-being, and salivary cortisol. Evid. Based Complement. Altern. Med. 2012, 2012:234713.
14. Boyer P. Do anxiety and depression have a common pathophysiological mechanism?. Acta Psychiatr. Scand. Suppl. 2000, (406):24-29.
15. Buijs R.M. The autonomic nervous system: a balancing act. Handb. Clin. Neurol. 2013, 117:1-11.
16. Butler L.D., et al. Meditation with yoga, group therapy with hypnosis, and psychoeducation for long-term depressed mood: a randomized pilot trial. J.Clin. Psychol. 2008, 64(7):806-820.
17. Capuron L., Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav. Immun. 2003, 17(Suppl.1):S119-S124.
18. Capuron L., et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 2002, 26(5):643-652.
19. Capuron L., et al. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol. Psychiatry 2005, 58(3):190-196.
20. Capuron L., Miller A.H. Cytokines and psychopathology: lessons from interferon-alpha. Biol. Psychiatry 2004, 56(11):819-824.
21. Chandwani K.D., et al. Randomized, controlled trial of yoga in women with breast cancer undergoing radiotherapy. J.Clin. Oncol. 2014, 32(10):1058-1065.
22. Chattha R., et al. Treating the climacteric symptoms in Indian women with an integrated approach to yoga therapy: a randomized control study. Menopause 2008, 15(5):862-870.
23. Cheema B.S., et al. Effect of an office worksite-based yoga program on heart rate variability: outcomes of a randomized controlled trial. BMC Complement. Altern. Med. 2013, 13:82.
24. Chen K.W., et al. Meditative therapies for reducing anxiety: a systematic review and meta-analysis of randomized controlled trials. Depress. Anxiety 2012, 29(7):545-562.
25. Clarke T.C., et al. Trends in the use of complementary health approaches among adults: United States, 2002-2012. Natl. Health Stat. Rep. 2015, (79):1-16.
26. Clow A., et al. The awakening cortisol response: methodological issues and significance. Stress 2004, 7(1):29-37.
27. Cohen D.L., et al. Cerebral blood flow effects of yoga training: preliminary evaluation of 4 cases. J.Altern. Complement. Med. 2009, 15(1):9-14.
28. Corey S.M., et al. Effect of restorative yoga vs. stretching on diurnal cortisol dynamics and psychosocial outcomes in individuals with the metabolic syndrome: the PRYSMS randomized controlled trial. Psychoneuroendocrinology 2014, 49:260-271.
29. Craft L.L., Perna F.M. The benefits of exercise for the clinically depressed. Prim. Care Companion J. Clin. Psychiatry 2004, 6(3):104-111.
30. Craig A.D. Interoception: the sense of the physiological condition of the body. Curr. Opin. Neurobiol. 2003, 13(4):500-505.
31. Cramer H., et al. Yoga for depression: a systematic review and meta-analysis. Depress. Anxiety 2013, 30(11):1068-1083.
32. D'Silva S., et al. Mind-body medicine therapies for a range of depression severity: a systematic review. Psychosomatics 2012, 53(5):407-423.
33. Dantzer R. Depression and inflammation: an intricate relationship. Biol. Psychiatry 2012, 71(1):4-5.
34. Dantzer R., et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 2008, 9(1):46-56.
35. Danucalov M.A., et al. Ayoga and compassion meditation program reduces stress in familial caregivers of Alzheimer's disease patients. Evid. Based Complement. Altern. Med. 2013, 2013:513149.
36. Davidson R.J. Affective neuroscience and psychophysiology: toward a synthesis. Psychophysiology 2003, 40(5):655-665.
37. Davis M. The role of the amygdala in fear and anxiety. Annu. Rev. Neurosci. 1992, 15:353-375.
38. Decety J., Jackson P.L. The functional architecture of human empathy. Behav. Cogn. Neurosci. Rev. 2004, 3(2):71-100.
39. Ding D., Stamatakis E. Yoga practice in England 1997-2008: prevalence, temporal trends, and correlates of participation. BMC Res. Notes 2014, 7:172.
40. Drevets W.C. Functional neuroimaging studies of depression: the anatomy of melancholia. Annu. Rev. Med. 1998, 49:341-361.
41. Drevets W.C. Prefrontal cortical-amygdalar metabolism in major depression. Adv. Ventral Striatum Ext. Amygdala 1999, 877:614-637.
42. Ebnezar J., et al. Effect of integrated yoga therapy on pain, morning stiffness and anxiety in osteoarthritis of the knee joint: a randomized control study. Int. J. Yoga 2012, 5(1):28-36.
43. Edwards S., et al. Exploration of the awakening cortisol response in relation to diurnal cortisol secretory activity. Life Sci. 2001, 68(18):2093-2103.
44. Eison M.S. Serotonin: a common neurobiologic substrate in anxiety and depression. J.Clin. Psychopharmacol. 1990, 10(3 Suppl.l):26S-30S.
45. Eren I., et al. Evaluation of regional cerebral blood flow changes in panic disorder with Tc99m-HMPAO SPECT. Psychiatry Research-Neuroimaging 2003, 123(2):135-143.
46. Farmer J. Yoga body: the origins of modern posture practice. Rev. Am. Hist. 2012, 40(1):145-158.
47. Field T., et al. Yoga and social support reduce prenatal depression, anxiety and cortisol. J.Bodyw. Mov. Ther. 2013, 17(4):397-403.
48. Fries G.R., et al. Staging and neuroprogression in bipolar disorder. Curr. Psychiatry Rep. 2012, 14(6):667-675.
49. Frodl T., et al. Hippocampal changes in patients with a first episode of major depression. Am. J. Psychiatry 2002, 159(7):1112-1118.
50. G F The Yoga Tradition 1998, Hohm Press, Prescott.
51. Gaykema R.P., Goehler L.E. Ascending caudal medullary catecholamine pathways drive sickness-induced deficits in exploratory behavior: brain substrates for fatigue?. Brain Behav. Immun. 2011, 25(3):443-460.
52. Goehler L.E., et al. Vagal immune-to-brain communication: a visceral chemosensory pathway. Auton. Neurosci. 2000, 85(1-3):49-59.
53. Goodyer I.M., et al. Adrenal secretion during major depression in 8- to 16-year-olds .1. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med. 1996, 26(2):245-256.
54. Gopal A., et al. Effect of integrated yoga practices on immune responses in examination stress - a preliminary study. Int. J. Yoga 2011, 4(1):26-32.
55. Goyal M., et al. Meditation programs for psychological stress and well-being: a systematic review and meta-analysis. JAMA Intern Med. 2014, 174(3):357-368.
56. Granath J., et al. Stress management: a randomized study of cognitive behavioural therapy and yoga. Cogn. Behav. Ther. 2006, 35(1):3-10.
57. Granger D.A., et al. Medication effects on salivary cortisol: tactics and strategy to minimize impact in behavioral and developmental science. Psychoneuroendocrinology 2009, 34(10):1437-1448.
58. Gustavsson A., et al. Cost of disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 2011, 21(10):718-779.
59. Hallgren M., et al. Yoga as an adjunct treatment for alcohol dependence: a pilot study. Complement. Ther. Med. 2014, 22(3):441-445.
60. Harinath K., et al. Effects of Hatha yoga and Omkar meditation on cardiorespiratory performance, psychologic profile, and melatonin secretion. J.Altern. Complement. Med. 2004, 10(2):261-268.
61. Hariprasad V.R., et al. Yoga increases the volume of the hippocampus in elderly subjects. Indian J. Psychiatry 2013, 55(Suppl.3):S394-S396.
62. Herman J.P., et al. Limbic system mechanisms of stress regulation: hypothalamo-pituitary-adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29(8):1201-1213.
63. Howland R.H. Pharmacotherapy strategies for treatment-resistant depression. J.Psychosoc. Nurs. Ment. Health Serv. 2006, 44(11):11-14.
64. Hranov L.G. Comorbid anxiety and depression: illumination of a controversy. Int. J. Psychiatry Clin. Pract. 2007, 11(3):171-189.
65. Innes K.E., Selfe T.K. The effects of a gentle yoga program on sleep, mood, and blood pressure in older women with restless legs syndrome (RLS): a preliminary randomized controlled trial. Evid. Based Complement. Altern. Med. 2012, 2012:294058.
66. Ionescu D.F., et al. Neurobiology of anxious depression: a review. Depress. Anxiety 2013, 30(4):374-385.
67. Issakidis C., Andrews G. Service utilisation for anxiety in an Australian community sample. Soc. Psychiatry Psychiatr. Epidemiol. 2002, 37(4):153-163.
68. Jackson P.L., et al. Empathy examined through the neural mechanisms involved in imagining how I feel versus how you feel pain. Neuropsychologia 2006, 44(5):752-761.
69. John P.J., et al. Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache 2007, 47(5):654-661.
70. Johnson J., Weissman M.M., Klerman G.L. Panic disorder, comorbidity, and suicide attempts. Arch. Gen. Psychiatry 1990, 47(9):805-808.
71. Jorm A.F., et al. Public belief systems about the helpfulness of interventions for depression: associations with history of depression and professional help-seeking. Soc. Psychiatry Psychiatr. Epidemiol. 2000, 35(5):211-219.
72. Jorm A.F., et al. Public beliefs about the helpfulness of interventions for depression: effects on actions taken when experiencing anxiety and depression symptoms. Aust. N. Z. J. Psychiatry 2000, 34(4):619-626.
73. Kanojia S., et al. Effect of yoga on autonomic functions and psychological status during both phases of menstrual cycle in young healthy females. J.Clin. Diagn Res. 2013, 7(10):2133-2139.
74. Kempton M.J., et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch. Gen. Psychiatry 2011, 68(7):675-690.
75. Kiecolt-Glaser J.K., et al. Yoga's impact on inflammation, mood, and fatigue in breast cancer survivors: a randomized controlled trial. J.Clin. Oncol. 2014, 32(10):1040-1049.
76. King S.L., Hegadoren K.M. Stress hormones: how do they measure up?. Biol. Res. Nurs. 2002, 4(2):92-103.
77. Kinser P.A., Goehler L.E., Taylor A.G. How might yoga help depression? a neurobiological perspective. Explore J. Sci. Heal. 2012, 8(2):118-126.
78. Kirsch I., et al. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the food and drug Administration. PLoS Med. 2008, 5(2):e45.
79. Kjellgren A., et al. Wellness through a comprehensive yogic breathing program - a controlled pilot trial. BMC Complement. Altern. Med. 2007, 7:43.
80. Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature 2008, 455(7215):894-902.
81. Kubera M., et al. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 2000, 25(8):785-797.
82. Kudielka B.M., Kirschbaum C. Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology 2003, 28(1):35-47.
83. Kulp A., Kuehn M.J. Biological functions and biogenesis of secreted bacterial outer membrane vesicles. Annu. Rev. Microbiol. 2010, 64:163-184.
84. Li A.W., Goldsmith C.A. The effects of yoga on anxiety and stress. Altern. Med. Rev. 2012, 17(1):21-35.
85. Lutz A., D.J., Davidson R.J. Meditation and the neuroscience of consciousness. Cambridge Handbook of Consciousness 2007, 499-554. Cambridge University Press, Cambridge. Z. P (Ed.).
86. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuroendocrinol. Lett. 2008, 29(3):287-291.
87. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol. Lett. 2008, 29(3):287-291.
88. Malathi A., et al. Psychophysiological changes at the time of examination in medical students before and after the practice of yoga and relaxation. Indian J. Psychiatry 1998, 40(1):35-40.
89. Masi G., Brovedani P. The hippocampus, neurotrophic factors and depression: possible implications for the pharmacotherapy of depression. CNS Drugs 2011, 25(11):913-931.
90. Mastorakos G., Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann. N. Y. Acad. Sci. 2003, 997:136-149.
91. Mathew A.R., et al. Co-morbidity between major depressive disorder and anxiety disorders: shared etiology or direct causation?. Psychol. Med. 2011, 41(10):2023-2034.
92. McCall M.C. How might yoga work? an overview of potential underlying mechanisms. Yoga Phys. Ther. 2013, 3(1).
93. McDermott K.A., et al. Ayoga intervention for type 2 diabetes risk reduction: a pilot randomized controlled trial. BMC Complement. Altern. Med. 2014, 14:212.
94. McEwen B.S. Mood disorders and allostatic load. Biol. Psychiatry 2003, 54(3):200-207.
95. McIntyre R.S., et al. The association between conventional antidepressants and the metabolic syndrome a review of the evidence and clinical implications. Cns Drugs 2010, 24(9):741-753.
96. Michel T.M., Pulschen D., Thome J. The role of oxidative stress in depressive disorders. Curr. Pharm. Des. 2012, 18(36):5890-5899.
97. Miller E.K., Freedman D.J., Wallis J.D. The prefrontal cortex: categories, concepts and cognition. Philos. Trans. R. Soc. Lond B Biol. Sci. 2002, 357(1424):1123-1136.
98. Morilak D.A., Frazer A. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders. Int. J. Neuropsychopharmacol. 2004, 7(2):193-218.
99. Musselman D.L., et al. Paroxetine for the prevention of depression induced by high-dose interferon alfa. N.Engl. J. Med. 2001, 344(13):961-966.
100. Neale M.C., Kendler K.S. Models of comorbidity for multifactorial disorders. Am. J. Hum. Genet. 1995, 57(4):935-953.
101. Nerurkar A., et al. When conventional medical providers recommend unconventional medicine: results of a national study. Arch. Intern Med. 2011, 171(9):862-864.
102. Newham J.J., et al. Effects of antenatal yoga on maternal anxiety and depression: a randomized controlled trial. Depress Anxiety 2014, 31(8):631-640.
103. Nutt D., Argyropoulos S., F.S Generalized Anxiety Disorder: Diagnosis, Treatment and its Relationship to Other Anxiety Disorders 1998, Martin Dunitz Ltd, London.
104. Olesen J., et al. The economic cost of brain disorders in Europe. Eur. J. Neurol. 2012, 19(1):155-162.
105. Olson K.L., Marc D.T., Grude L.A., McManus C.J., Kellermann G.H. The hypothalamic-pituitary-adrenal axis: the actions of the Central Nervous System and Potential Biomarkers. Anti-aging Therapeutics 2012, vol. XIII:91-100. American Academy of Anti-Aging Medicine, Chicago, IL USA, 201.
106. Organisation, W.H Depression Factsheet 2013.
107. Ospina M.B., et al. Meditation practices for health: state of the research. Evid. Rep. Technol. Assess. (Full Rep.) 2007, (155). 1-263.
108. Pascoe M.C., et al. Inflammation and depression: why poststroke depression may be the norm and not the exception. Int. J. Stroke 2011, 6(2):128-135.
109. Penman S., et al. Yoga in Australia: results of a national survey. Int. J. Yoga 2012, 5(2):92-101.
110. Pflueger L.W. Yoga body: the origins of modern posture practice. Relig. Stud. Rev. 2011, 37(3). 235-235.
111. Piet J., Hougaard E. The effect of mindfulness-based cognitive therapy for prevention of relapse in recurrent major depressive disorder: a systematic review and meta-analysis. Clin. Psychol. Rev. 2011, 31(6):1032-1040.
112. Pilkington K., et al. Yoga for depression: the research evidence. J.Affect Disord. 2005, 89(1-3):13-24.
113. Poll E.M., et al. Saliva collection method affects predictability of serum cortisol. Clin. Chim. Acta 2007, 382(1-2):15-19.
114. Raison C.L., et al. Arandomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry 2013, 70(1):31-41.
115. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27(1):24-31.
116. Rocha K.K., et al. Improvement in physiological and psychological parameters after 6 months of yoga practice. Conscious Cogn. 2012, 21(2):843-850.
117. Roy-Byrne P.P., et al. The corticotropin-releasing hormone stimulation test in patients with panic disorder. Am. J. Psychiatry 1986, 143(7):896-899.
118. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21(1):55-89.
119. Sarubin N., et al. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial. J.Psychiatr. Res. 2014, 53:76-83.
120. Schatzberg A.F. Safety and tolerability of antidepressants: weighing the impact on treatment decisions. J.Clin. Psychiatry 2007, 68(Suppl.8):26-34.
121. Schulberg H.C., Katon W.J., Shear M.K. Management of mood and anxiety disorders in primary care. Mood and Anxiety Disorders 1998, Current Science Inc, Philadelphia, PA. A.J. Rush (Ed.).
122. Sharma V.K., et al. Effect of Sahaj Yoga on neuro-cognitive functions in patients suffering from major depression. Indian J. Physiol. Pharmacol. 2006, 50(4):375-383.
123. Sheline Y.I., Gado M.H., Kraemer H.C. Untreated depression and hippocampal volume loss. Am. J. Psychiatry 2003, 160(8):1516-1518.
124. Shyn S.I., Hamilton S.P. The genetics of major depression: moving beyond the monoamine hypothesis. Psychiatr. Clin. North Am. 2010, 33(1):125-140.
125. Siegle G.J., et al. Can't shake that feeling: assessment of sustained event-related fMRI amygdala activity in response to emotional information in depressed individuals. Biol. Psychiatry 2002, 51(9):693-707.
126. da Silva T.L., Ravindran L.N., Ravindran A.V. Yoga in the treatment of mood and anxiety disorders: a review. Asian J. Psychiatr. 2009, 2(1):6-16.
127. Silverman M.N., Sternberg E.M. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann. N. Y. Acad. Sci. 2012, 1261:55-63.
128. Smith C., et al. Arandomised comparative trial of yoga and relaxation to reduce stress and anxiety. Complement. Ther. Med. 2007, 15(2):77-83.
129. Streeter C.C., et al. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J.Altern. Complement. Med. 2010, 16(11):1145-1152.
130. Streeter C.C., et al. Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J.Altern. Complementary Med. 2010, 16(11):1145-1152.
131. Streeter C.C., et al. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med. Hypotheses 2012, 78(5):571-579.
132. Sujatha T., J.A Efectivenes of a 12-Wek yoga program on physiopsychological parameters in patients with hypertension. Int. J. Pharm. Clin. Res. 2014, 6(4):329-335.
133. Telles S., et al. Post traumatic stress symptoms and heart rate variability in Bihar flood survivors following yoga: a randomized controlled study. BMC Psychiatry 2010, 10:18.
134. Tindle H.A., et al. Trends in use of complementary and alternative medicine by us adults: 1997-2002. Altern. Ther. Health Med. 2005, 11(1):42-49.
135. Tolbanos Roche L., Mas Hesse B. Application of an integrative yoga therapy programme in cases of essential arterial hypertension in public healthcare. Complement. Ther. Clin. Pract. 2014, 20(4):285-290. 10.1016/j.ctcp.2014.10.004.
136. Travis F., Pearson C. Pure consciousness: distinct phenomenological and physiological correlates of "consciousness itself". Int. J. Neurosci. 2000, 100(1-4):77-89.
137. Uebelacker L.A., et al. Hatha yoga for depression: critical review of the evidence for efficacy, plausible mechanisms of action, and directions for future research. J.Psychiatr. Pract. 2010, 16(1):22-33.
138. Vadiraja H.S., et al. Effects of a yoga program on cortisol rhythm and mood states in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial. Integr. Cancer Ther. 2009, 8(1):37-46.
139. Wardle J., Adams J., Sibbritt D. Referral to yoga therapists in rural primary health care: a survey of general practitioners in rural and regional New South Wales, Australia. Int. J. Yoga 2014, 7(1):9-16.
140. Weibel L. Methodological guidelines for the use of salivary cortisol as biological marker of stress. Presse Med. 2003, 32(18):845-851.
141. West J., et al. Effects of Hatha yoga and African dance on perceived stress, affect, and salivary cortisol. Ann. Behav. Med. 2004, 28(2):114-118.
142. Whiteford H.A., et al. Global burden of disease attributable to mental and substance use disorders: findings from the global Burden of Disease Study 2010. Lancet 2013, 382(9904):1575-1586.
143. Wittchen H.U., et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol. 2011, 21(9):655-679.
144. Woolery A., et al. Ayoga intervention for young adults with elevated symptoms of depression. Altern. Ther. Health Med. 2004, 10(2):60-63.
145. Yang Y., Raine A. Prefrontal structural and functional brain imaging findings in antisocial, violent, and psychopathic individuals: a meta-analysis. Psychiatry Res. 2009, 174(2):81-88.
146. Yeung A., et al. Randomised controlled trial of a 12 week yoga intervention on negative affective states, cardiovascular and cognitive function in post-cardiac rehabilitation patients. BMC Complement. Altern. Med. 2014, 14:411.
147. del Zoppo G., et al. Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol. 2000, 10(1):95-112.